CMI_LatestReportOrientedBlogs

  Cardiac Biomarkers  Cardiac biomarkers are circulating proteins that are produced by the heart. They are produced when tissue damage or necrosis occurs in the heart, such as in myocardial infarction. Myoglobin is one such protein and it is not specific to myocardial infarction. Creatine kinase and troponin are also detected in blood within 3-4 hours of myocardial infarction. Myoglobin is a hemeprotein found in both skeletal and cardiac muscle. Myoglobin levels increase first in the heart, which is why Cardiac Biomarkers are considered early markers of heart attack. However, myoglobin increases after noncardiac trauma and may not be used alone as a marker for heart attacks. So, it may not be the best choice as a sole marker. To determine whether a certain biomarker is present in the blood, it is important to identify its level and the underlying cause. Using several biomarkers can increase the sensitivity and specificity of the test. Multiple biomarkers are particularly useful for

  Metabolic testing involves assessment of health and wellbeing of an individual. Metabolic testing equipment are used to screen organ functions and disease conditions such as liver diseases, diabetes, kidney diseases, and cardiovascular diseases. In case of sports professionals, metabolic testing is completed in order to test body's ability of oxygen consumption. Metabolic syndrome is a small grouping of metabolic disorders such as high blood pressure with high fasting glucose levels and abnormal obesity. Metabolism is really a chemical reaction occurring in the torso to steadfastly keep up the conventional state of the organism or body. Metabolism pattern and metabolic capacity is determined with assistance from metabolic testing for management of such conditions. On the foundation of products, industry is segmented into CPET systems, metabolic carts, ECGs and EKGs, body composition analyzers, and software. The global Metabolic Testing Market is segmented on the foundation of pr

  Optogenetics Optogenetics can be an emerging medical technique, which involves the usage of light to manage cells in living tissues, especially neurons to greatly help study the characteristics of normal and abnormal brain function. Optogenetics can be an emerging field of biotechnology trending among the fields of neuroscience, cardiology, ophthalmology, behavioral science, and other healthcare domains. The technique is widely used to deal with neurological disorders such as for instance depression. Depression is caused by chronic stress that creates a series of negative memories. Key players in the Optogenetics market include Coherent, Inc., Thorlabs, Inc. Cobalt, Inc., Scientifica, Laserglow Technologies, Regenxbio, Inc., Gensight, Addgene, UPenn Vector Core, and Jackson Laboratories. The main element players are focusing on strategic mergers and acquisitions and development of innovative systems. For example, Coherent Inc. launched a brand new kind of short pulse ultrafast lase